Oaktop Capital Management II’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,500	Closed	-$566K	–	17
2020 Q4	$566K	Hold	12,500	–	–	0.1%	18
2020 Q3	$442K	Hold	12,500	–	–	0.1%	19
2020 Q2	$472K	Hold	12,500	–	–	0.11%	20
2020 Q1	$361K	Hold	12,500	–	–	0.11%	19
2019 Q4	$648K	Hold	12,500	–	–	0.17%	17
2019 Q3	$686K	Hold	12,500	–	–	0.14%	15
2019 Q2	$508K	Hold	12,500	–	–	0.11%	17
2019 Q1	$378K	Hold	12,500	–	–	0.08%	18
2018 Q4	$420K	Hold	12,500	–	–	0.12%	16
2018 Q3	$527K	Hold	12,500	–	–	0.12%	18
2018 Q2	$400K	Hold	12,500	–	–	0.09%	18
2018 Q1	$622K	Hold	12,500	–	–	0.13%	18
2017 Q4	$674K	Hold	12,500	–	–	0.14%	19
2017 Q3	$725K	Hold	12,500	–	–	0.12%	19
2017 Q2	$617K	Hold	12,500	–	–	0.11%	20
2017 Q1	$543K	Hold	12,500	–	–	0.11%	20
2016 Q4	$612K	Hold	12,500	–	–	0.13%	18
2016 Q3	$598K	Hold	12,500	–	–	0.14%	18
2016 Q2	$671K	Hold	12,500	–	–	0.16%	18
2016 Q1	$559K	Hold	12,500	–	–	0.14%	17
2015 Q4	$477K	Hold	12,500	–	–	0.11%	18
2015 Q3	$398K	Hold	12,500	–	–	0.09%	21
2015 Q2	$413K	Hold	12,500	–	–	0.09%	20
2015 Q1	$515K	Hold	12,500	–	–	0.11%	20
2014 Q4	$509K	Hold	12,500	–	–	0.11%	19
2014 Q3	$458K	Hold	12,500	–	–	0.11%	20
2014 Q2	$579K	Hold	12,500	–	–	0.13%	20
2014 Q1	$514K	Hold	12,500	–	–	0.13%	20
2013 Q4	$477K	Hold	12,500	–	–	0.11%	20
2013 Q3	$299K	Hold	12,500	–	–	0.08%	20
2013 Q2	$213K	Buy	+12,500	New	+$213K	0.06%	19